Small CRO niche Target drug discovery programs in need of integrated medicinal chemistry and DMPK support, especially startups and mid-stage biotech firms developing small molecule therapeutics who require scalable non-GMP API intermediates and early process development.

Full-service enablement Leverage Synovel’s END-to-END offering spanning compound design, synthesis, process optimization, polymorph analysis, and regulatory documentation to position as a one-stop partner for IND enabling activities.

Regulatory readiness Highlight capabilities in GLP tooling, bioanalysis data management, PK consulting, and IND/BLA/NDA document preparation to address sponsors seeking compliant, audit-ready workflows and regulatory submissions.

Global standards appeal Emphasize readiness to respond to FDA, EMA, and PMDA inquiries, positioning as a capable partner for multinational programs that require diverse regulatory support and cross-border coordination.

Tech-enabled efficiency Showcase integration of modern data and software tools (custom tracking for samples, PK code development, and analytical method development) as a means to improve project transparency, traceability, and turnaround times for complex programs.